| Neurology & Pain Specialty Center | |
|
5 Journey Ste 210 Aliso Viejo CA 92656-5332 | |
| (949) 305-7122 | |
| (949) 305-7160 |
| Full Name | Neurology & Pain Specialty Center |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 5 Journey Ste 210, Aliso Viejo, California |
| Authorized Official Name and Position | Kenneth Patrick Martinez (NEUROLOGIST) |
| Authorized Official Contact | 9493057122 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Neurology & Pain Specialty Center 5 Journey Suite 210 Aliso Viejo CA 92656-5336 Ph: (949) 305-7122 | Neurology & Pain Specialty Center 5 Journey Ste 210 Aliso Viejo CA 92656-5332 Ph: (949) 305-7122 |
| NPI Number | 1255537957 |
|---|---|
| Provider Enumeration Date | 06/21/2007 |
| Last Update Date | 07/21/2022 |
| Certification Date | 01/07/2020 |
| Medicare PECOS PAC ID | 9133115629 |
|---|---|
| Medicare Enrollment ID | O20040421000850 |
News Archive
Experts from across the world will meet to discuss the implementation of a pioneering non-invasive test to determine the blood type of unborn babies at an event hosted by the University of Warwick.
Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients, today reported that it has greatly expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced the acquisition of patents for DJ5, a novel non-TZD PPARgamma agonist with potential to retard progressive renal failure in patients with autosomal dominant polycystic kidney disease ("ADPKD').
The U.S. Food and Drug Administration has announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255537957 | NPI | - | NPPES |
| A66709 | Other | CA | CA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | (California) | Primary |
| Provider Name | Kenneth P Martinez |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1093825259 PECOS PAC ID: 1153317656 Enrollment ID: I20040422001240 |
News Archive
Experts from across the world will meet to discuss the implementation of a pioneering non-invasive test to determine the blood type of unborn babies at an event hosted by the University of Warwick.
Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients, today reported that it has greatly expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced the acquisition of patents for DJ5, a novel non-TZD PPARgamma agonist with potential to retard progressive renal failure in patients with autosomal dominant polycystic kidney disease ("ADPKD').
The U.S. Food and Drug Administration has announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms.
› Verified 4 days ago
News Archive
Experts from across the world will meet to discuss the implementation of a pioneering non-invasive test to determine the blood type of unborn babies at an event hosted by the University of Warwick.
Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients, today reported that it has greatly expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced the acquisition of patents for DJ5, a novel non-TZD PPARgamma agonist with potential to retard progressive renal failure in patients with autosomal dominant polycystic kidney disease ("ADPKD').
The U.S. Food and Drug Administration has announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms.
› Verified 4 days ago
Abridge To Healing Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13 Waxwing Ln, Aliso Viejo, CA 92656 Phone: 949-542-5105 Fax: 949-552-5243 | |
Phoenix Rising Behavioral Health Care Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 92 Argonaut Ste 170, Aliso Viejo, CA 92656 Phone: 949-463-8381 | |
Akoya Wellness And Family Counseling, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 28520 Wood Canyon Dr Apt 14, Aliso Viejo, CA 92656 Phone: 949-257-2229 | |
Orange County Health Care Agency Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Mareblu, Aliso Viejo, CA 92656 Phone: 949-643-6930 | |
Amhs Aliso Viejo Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Mareblu, Suite 200, 250, Aliso Viejo, CA 92656 Phone: 949-643-6930 Fax: 949-362-5834 | |
Risen Warriors Foundation Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 16b Journey, Aliso Viejo, CA 92656 Phone: 949-309-6681 Fax: 949-340-8399 |